SRTS

Sensus Healthcare, Inc.

SRTS | $3.355 -1.32% -1.34% 22K

(0.0% 1d) (-9.6% 1m) (-26.9% 1y) (0.0% 2d) (0.3% 3d) (0.9% 7d) (98.61% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 55,002,444
http://www.sensushealthcare.com
Sec Filling | Patents | 53 employees

(US) Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+ and SRT-100 Vision. Its main product, superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

skin energy cancer radiation therapy t-cell msa treatment photo ceiling

add to watch list Paper trade email alert is off

Press-releases

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| 0.89% | O: -3.26% H: 3.99% C: 0.92%
first conference business update financial results

Sensus Healthcare to Participate in the 36th Annual Roth Conference
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| -8.11% | O: 2.16% H: 7.28% C: -6.88%
conference

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| -4.23% | O: 0.0% H: 9.86% C: 9.58%
srt-100 meeting deal

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| -6.85% | O: 6.3% H: 2.58% C: 0.0%
year financial results

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
Published: 2024-02-08 (Crawled : 13:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| -6.59% | O: -0.55% H: 3.31% C: 0.83%
srt-100 vision patent system

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| 4.94% | O: 1.23% H: 6.71% C: 6.4%

Sensus Healthcare Announces Retirement of Director Samuel O’Rear
Published: 2024-02-01 (Crawled : 13:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| 4.62% | O: 0.31% H: 3.07% C: -0.61%

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
Published: 2024-01-30 (Crawled : 13:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| -1.73% | O: -0.87% H: 0.29% C: -3.5%
conference business year update financial results

Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
Published: 2024-01-23 (Crawled : 13:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| 27.82% | O: 24.06% H: 10.61% C: 1.82%
million revenue

Sensus Healthcare Reports Third Quarter 2023 Financial Results
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
SRTS | $3.355 -1.32% -1.34% 22K

Health Technology

| 53.15% | O: -16.67% H: 17.82% C: 2.7%
financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-001064	4	2024-01-16	2024-01-11	Buy	A	20000	78774
0001415889-23-016774	4	2023-12-20	2023-12-19	Sell	F	741	9759
0001415889-23-013321	4	2023-09-18	2023-09-14	Buy	P	10000	1175293
0001415889-23-012715	4	2023-08-28	2023-08-28	Buy	P	1000	58774